companydata.dkcompanydata.dk

Cyclomedica Danmark ApS: Financial statements 2020

CVR: 16582891

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

Cyclomedica Danmark ApS (CVR 16582891) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,272,571 and a net result of DKK 115,417 compared with DKK 424,845 the year before. That is a decrease of 26.8% compared with the year before. Equity in the 2020 report amounted to DKK 1,911,293. The solvency ratio was 58.4%. The company had 3 employees in the financial year.

Gross Profit
DKK 1,272,571
Profit/Loss
DKK 115,417
Equity
DKK 1,911,293
Total Assets
DKK 3,271,955
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-1.3M115K1.9M3
2019-1.7M425K2.2M3
2018-1.7M373K2.1M3
2017-2.7M853K2.5M3
2016-3.4M1.7M3.2M3

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Cyclomedica Danmark ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Cyclomedica Danmark ApS: The 2019 annual report is outMar 17, 2020

Cyclomedica Danmark ApS has published its annual report for 2019. Gross profit came to DKK 1,739,525, and the net result was DKK 424,845.

About Cyclomedica Danmark ApS

Cyclomedica Danmark ApS is a Danish company of the type Anpartsselskab based in Kastrup, founded in 1992. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named DUPHARMA ApS and DUPHARMA A/S. The management consists of Jan Fritz Rode Jakobsen. The board consists of James Steven Mc Brayer and Mathew Farag. The company is owned by Cyclomedia Europe Limited. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 559,660 and a net result of DKK 135,961 compared with DKK -5,806 the year before. Equity in the 2025 report amounted to DKK 478,864.

Source: annual report 2025, Danish Business Authority